Packaging & Containers
Compare Stocks
5 / 10Stock Comparison
MYE vs AIN vs ESE vs IOSP vs ITRI
Revenue, margins, valuation, and 5-year total return — side by side.
Apparel - Manufacturers
Hardware, Equipment & Parts
Chemicals - Specialty
Hardware, Equipment & Parts
MYE vs AIN vs ESE vs IOSP vs ITRI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaging & Containers | Apparel - Manufacturers | Hardware, Equipment & Parts | Chemicals - Specialty | Hardware, Equipment & Parts |
| Market Cap | $859M | $1.77B | $7.85B | $2.00B | $3.63B |
| Revenue (TTM) | $784M | $1.21B | $1.25B | $1.79B | $2.35B |
| Net Income (TTM) | $42M | $-59M | $308M | $114M | $289M |
| Gross Margin | 33.6% | 20.5% | 21.7% | 27.4% | 38.6% |
| Operating Margin | 10.6% | -2.0% | 13.7% | 8.3% | 13.2% |
| Forward P/E | 18.8x | 24.1x | 37.1x | 16.2x | 13.6x |
| Total Debt | $379M | $456M | $230M | $90M | $1.29B |
| Cash & Equiv. | $45M | $112M | $101M | $293M | $1.02B |
MYE vs AIN vs ESE vs IOSP vs ITRI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Myers Industries, I… (MYE) | 100 | 168.7 | +68.7% |
| Albany Internationa… (AIN) | 100 | 103.7 | +3.7% |
| ESCO Technologies I… (ESE) | 100 | 366.9 | +266.9% |
| Innospec Inc. (IOSP) | 100 | 104.5 | +4.5% |
| Itron, Inc. (ITRI) | 100 | 127.1 | +27.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MYE vs AIN vs ESE vs IOSP vs ITRI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MYE is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 2.4% yield, vs IOSP's 2.1%, (1 stock pays no dividend)
- +93.9% vs ITRI's -24.1%
Among these 5 stocks, AIN doesn't own a clear edge in any measured category.
ESE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 19.2%, EPS growth 193.1%, 3Y rev CAGR 8.5%
- 7.0% 10Y total return vs MYE's 99.4%
- 19.2% revenue growth vs AIN's -3.9%
- 24.7% margin vs AIN's -4.9%
IOSP ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.71, yield 2.1%
- Lower volatility, beta 0.71, Low D/E 6.7%, current ratio 2.79x
- PEG 0.51 vs ESE's 0.55
- Beta 0.71, yield 2.1%, current ratio 2.79x
ITRI is the clearest fit if your priority is value.
- Lower P/E (13.6x vs 37.1x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.2% revenue growth vs AIN's -3.9% | |
| Value | Lower P/E (13.6x vs 37.1x) | |
| Quality / Margins | 24.7% margin vs AIN's -4.9% | |
| Stability / Safety | Beta 0.71 vs ITRI's 1.52, lower leverage | |
| Dividends | 2.4% yield, vs IOSP's 2.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | +93.9% vs ITRI's -24.1% | |
| Efficiency (ROA) | 12.7% ROA vs AIN's -3.5%, ROIC 8.7% vs -1.1% |
MYE vs AIN vs ESE vs IOSP vs ITRI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MYE vs AIN vs ESE vs IOSP vs ITRI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ESE leads in 2 of 6 categories
ITRI leads 1 • MYE leads 0 • AIN leads 0 • IOSP leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ESE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ITRI is the larger business by revenue, generating $2.3B annually — 3.0x MYE's $784M. ESE is the more profitable business, keeping 24.7% of every revenue dollar as net income compared to AIN's -4.9%. On growth, ESE holds the edge at +16.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $784M | $1.2B | $1.2B | $1.8B | $2.3B |
| EBITDAEarnings before interest/tax | $116M | $59M | $218M | $181M | $367M |
| Net IncomeAfter-tax profit | $42M | -$59M | $308M | $114M | $289M |
| Free Cash FlowCash after capex | $89M | $92M | $212M | $77M | $393M |
| Gross MarginGross profit ÷ Revenue | +33.6% | +20.5% | +21.7% | +27.4% | +38.6% |
| Operating MarginEBIT ÷ Revenue | +10.6% | -2.0% | +13.7% | +8.3% | +13.2% |
| Net MarginNet income ÷ Revenue | +5.4% | -4.9% | +24.7% | +6.4% | +12.3% |
| FCF MarginFCF ÷ Revenue | +11.4% | +7.7% | +17.0% | +4.3% | +16.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -20.4% | +7.8% | +16.5% | +2.8% | -3.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +105.6% | -3.6% | +11.7% | -6.9% | -16.9% |
Valuation Metrics
Evenly matched — IOSP and ITRI each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 12.6x trailing earnings, ITRI trades at a 52% valuation discount to ESE's 26.2x P/E. Adjusting for growth (PEG ratio), ESE offers better value at 0.39x vs IOSP's 0.54x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $859M | $1.8B | $7.8B | $2.0B | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $2.1B | $8.0B | $1.8B | $3.9B |
| Trailing P/EPrice ÷ TTM EPS | 24.69x | -32.24x | 26.24x | 17.25x | 12.58x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.82x | 24.13x | 37.13x | 16.24x | 13.63x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.39x | 0.54x | — |
| EV / EBITDAEnterprise value multiple | 10.42x | 29.51x | 32.15x | 8.76x | 10.57x |
| Price / SalesMarket cap ÷ Revenue | 1.04x | 1.50x | 7.17x | 1.13x | 1.53x |
| Price / BookPrice ÷ Book value/share | 2.93x | 2.53x | 5.10x | 1.51x | 2.17x |
| Price / FCFMarket cap ÷ FCF | 12.78x | 21.46x | 41.36x | 22.78x | 9.53x |
Profitability & Efficiency
ITRI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ESE delivers a 20.4% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-8 for AIN. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to MYE's 1.29x. On the Piotroski fundamental quality scale (0–9), ITRI scores 7/9 vs ESE's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.5% | -7.7% | +20.4% | +8.5% | +17.2% |
| ROA (TTM)Return on assets | +4.9% | -3.5% | +12.7% | +6.3% | +7.7% |
| ROICReturn on invested capital | +8.8% | -1.1% | +8.7% | +11.2% | +13.1% |
| ROCEReturn on capital employed | +10.8% | -1.2% | +10.2% | +11.0% | +11.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 3 | 6 | 7 |
| Debt / EquityFinancial leverage | 1.29x | 0.62x | 0.15x | 0.07x | 0.74x |
| Net DebtTotal debt minus cash | $334M | $343M | $129M | -$203M | $267M |
| Cash & Equiv.Liquid assets | $45M | $112M | $101M | $293M | $1.0B |
| Total DebtShort + long-term debt | $379M | $456M | $230M | $90M | $1.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.02x | -0.95x | 7.86x | — | 14.38x |
Total Returns (Dividends Reinvested)
ESE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ESE five years ago would be worth $29,178 today (with dividends reinvested), compared to $7,677 for AIN. Over the past 12 months, MYE leads with a +93.9% total return vs ITRI's -24.1%. The 3-year compound annual growth rate (CAGR) favors ESE at 46.6% vs AIN's -10.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +24.1% | +20.0% | +53.5% | +5.6% | -13.3% |
| 1-Year ReturnPast 12 months | +93.9% | -2.4% | +74.6% | -11.9% | -24.1% |
| 3-Year ReturnCumulative with dividends | +29.2% | -27.5% | +215.3% | -13.4% | +21.9% |
| 5-Year ReturnCumulative with dividends | +18.2% | -23.2% | +191.8% | -12.7% | -3.8% |
| 10-Year ReturnCumulative with dividends | +99.4% | +86.8% | +695.4% | +92.6% | +96.2% |
| CAGR (3Y)Annualised 3-year return | +8.9% | -10.2% | +46.6% | -4.7% | +6.8% |
Risk & Volatility
Evenly matched — MYE and IOSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
IOSP is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than ITRI's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MYE currently trades 94.7% from its 52-week high vs ITRI's 57.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.31x | 1.34x | 1.10x | 0.71x | 1.52x |
| 52-Week HighHighest price in past year | $24.25 | $73.00 | $346.20 | $95.55 | $142.00 |
| 52-Week LowLowest price in past year | $11.69 | $41.15 | $170.11 | $65.58 | $78.53 |
| % of 52W HighCurrent price vs 52-week peak | +94.7% | +85.7% | +87.6% | +84.3% | +57.7% |
| RSI (14)Momentum oscillator 0–100 | 59.6 | 65.6 | 65.0 | 53.9 | 32.3 |
| Avg Volume (50D)Average daily shares traded | 214K | 247K | 306K | 224K | 887K |
Analyst Outlook
Evenly matched — MYE and IOSP each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MYE as "Buy", AIN as "Hold", ESE as "Buy", IOSP as "Hold", ITRI as "Hold". Consensus price targets imply 67.3% upside for ITRI (target: $137) vs -12.1% for AIN (target: $55). For income investors, MYE offers the higher dividend yield at 2.38% vs ESE's 0.11%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $26.00 | $55.00 | $350.00 | $115.00 | $137.00 |
| # AnalystsCovering analysts | 8 | 14 | 15 | 9 | 37 |
| Dividend YieldAnnual dividend ÷ price | +2.4% | +1.8% | +0.1% | +2.1% | — |
| Dividend StreakConsecutive years of raises | 0 | 8 | 1 | 12 | 1 |
| Dividend / ShareAnnual DPS | $0.55 | $1.10 | $0.32 | $1.70 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | +10.5% | 0.0% | 0.0% | +2.8% |
ESE leads in 2 of 6 categories (Income & Cash Flow, Total Returns). ITRI leads in 1 (Profitability & Efficiency). 3 tied.
MYE vs AIN vs ESE vs IOSP vs ITRI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MYE or AIN or ESE or IOSP or ITRI a better buy right now?
For growth investors, ESCO Technologies Inc.
(ESE) is the stronger pick with 19. 2% revenue growth year-over-year, versus -3. 9% for Albany International Corp. (AIN). Itron, Inc. (ITRI) offers the better valuation at 12. 6x trailing P/E (13. 6x forward), making it the more compelling value choice. Analysts rate Myers Industries, Inc. (MYE) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MYE or AIN or ESE or IOSP or ITRI?
On trailing P/E, Itron, Inc.
(ITRI) is the cheapest at 12. 6x versus ESCO Technologies Inc. at 26. 2x. On forward P/E, Itron, Inc. is actually cheaper at 13. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 51x versus ESCO Technologies Inc. 's 0. 55x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MYE or AIN or ESE or IOSP or ITRI?
Over the past 5 years, ESCO Technologies Inc.
(ESE) delivered a total return of +191. 8%, compared to -23. 2% for Albany International Corp. (AIN). Over 10 years, the gap is even starker: ESE returned +695. 4% versus AIN's +86. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MYE or AIN or ESE or IOSP or ITRI?
By beta (market sensitivity over 5 years), Innospec Inc.
(IOSP) is the lower-risk stock at 0. 71β versus Itron, Inc. 's 1. 52β — meaning ITRI is approximately 114% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 129% for Myers Industries, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MYE or AIN or ESE or IOSP or ITRI?
By revenue growth (latest reported year), ESCO Technologies Inc.
(ESE) is pulling ahead at 19. 2% versus -3. 9% for Albany International Corp. (AIN). On earnings-per-share growth, the picture is similar: Myers Industries, Inc. grew EPS 389. 5% year-over-year, compared to -169. 3% for Albany International Corp.. Over a 3-year CAGR, ITRI leads at 9. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MYE or AIN or ESE or IOSP or ITRI?
ESCO Technologies Inc.
(ESE) is the more profitable company, earning 27. 3% net margin versus -4. 8% for Albany International Corp. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ESE leads at 15. 8% versus -1. 4% for AIN. At the gross margin level — before operating expenses — ESE leads at 42. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MYE or AIN or ESE or IOSP or ITRI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 51x versus ESCO Technologies Inc. 's 0. 55x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Itron, Inc. (ITRI) trades at 13. 6x forward P/E versus 37. 1x for ESCO Technologies Inc. — 23. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITRI: 67. 3% to $137. 00.
08Which pays a better dividend — MYE or AIN or ESE or IOSP or ITRI?
In this comparison, MYE (2.
4% yield), IOSP (2. 1% yield), AIN (1. 8% yield), ESE (0. 1% yield) pay a dividend. ITRI does not pay a meaningful dividend and should not be held primarily for income.
09Is MYE or AIN or ESE or IOSP or ITRI better for a retirement portfolio?
For long-horizon retirement investors, Innospec Inc.
(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), 2. 1% yield). Itron, Inc. (ITRI) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IOSP: +92. 6%, ITRI: +96. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MYE and AIN and ESE and IOSP and ITRI?
These companies operate in different sectors (MYE (Consumer Cyclical) and AIN (Consumer Cyclical) and ESE (Technology) and IOSP (Basic Materials) and ITRI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MYE is a small-cap quality compounder stock; AIN is a small-cap quality compounder stock; ESE is a small-cap high-growth stock; IOSP is a small-cap deep-value stock; ITRI is a small-cap deep-value stock. MYE, AIN, IOSP pay a dividend while ESE, ITRI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.